Clear Search
Person filling out a form on a clipboard
UPDATED
·
10 Min Read

Competition in healthcare research

Learn about the current state of competition in health insurance markets across the U.S. and review in-depth analysis on market concentration.

Access to Care

Membership Moves Medicine™

  • Free access to JAMA Network™ and CME
  • Save hundreds on insurance
  • Fight for physicians and patient rights
Join the AMA
UPDATED
·
4 Min Read

What are pharmacy benefit managers (PBMs) and why we need reform?

PBM reform focuses on increasing transparency, ensuring savings reach patients and maintaining fair access to medications.

Access to Care
·
4 Min Read

AMA analysis: PBM market concentration continues to rise

Four largest PBMs held 75% of national market in 2024, while 94% of local PBM markets were highly concentrated.

Press Releases
10 states with the least competitive health insurance markets
·
3 Min Read

10 states with the least competitive health insurance markets

Find out if your state is on this top 10 list—one where patients and physicians definitely don’t want it to be. 

Access to Care
Large speech bubble eating a small speech bubble
·
5 Min Read

How health-insurance consolidation hurts patients, physicians

Learn how physicians can respond to arguments downplaying the harms of health-insurance consolidation.

Access to Care
Person holds two pieces of paper
·
3 Min Read

From city to city, health insurers hold outsized market share

The last decade has seen a drop in health insurance competition. Find out how it’s affecting the vast majority of U.S. metro areas. 

Access to Care
·
4 Min Read

AMA report: Health insurance giants tighten grip on U.S. markets

High company market share and troubling market concentration plague the health insurance industry.

Press Releases
UPDATED
·
6 Min Read

Ensuring health insurance competition

Discover the AMA's position on health insurance mergers and why the AMA believes fewer insurance carriers undermine physician practices and harm patient care.

Access to Care
·
6 Min Read

Oct. 31, 2025: National Advocacy Update

FDA issues new guidance aimed at speeding biosimilar time to market and lower costs, and more in the latest National Advocacy Update.

Advocacy Update